Renity Pharma AB

ABActive

Org 5594796137Kanalvägen 61, 191 34 SollentunaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2024 · 2 years old1-4 employees

Overview Financials People & ownership Related companies

Renity Pharma AB is a Swedish AB based in Sollentuna, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2024.

Revenue 2024

—

EBITDA margin

—

Net profit 2024

−59,3 t kr.

Key ratios

See full ratios →

−107,9 %

This company

20242024

0,5×

This company

20242024

−186,6 %

This company

20242024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	—	—
EBITDA	−59,3 t kr.	—
Net profit	−59,3 t kr.	—
Total assets	31,8 t kr.	—
Equity	−34,3 t kr.	—
Employees	—	—

Contact

Address

Kanalvägen 61, 191 34 Sollentuna

fredrik.lehmann@otpharma.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Renity Pharma AB?

Renity Pharma AB is registered with Bolagsverket / SCB under Org 5594796137.

Who is the CEO of Renity Pharma AB?

Per Fredrik Lehmann is the CEO of Renity Pharma AB.

Who is the chairman of Renity Pharma AB?

Krim Benaissa Talia chairs the board of Renity Pharma AB, in role since 2025.

Where is Renity Pharma AB headquartered?

Renity Pharma AB's registered address is Kanalvägen 61.

Renity Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Renity Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Renity Pharma AB

Financial development